SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001063
Filing Date
2023-05-12
Accepted
2023-05-12 09:09:47
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20230331x10q.htm   iXBRL 10-Q 1050955
2 EX-31.1 eyen-20230331xex31d1.htm EX-31.1 12884
3 EX-31.2 eyen-20230331xex31d2.htm EX-31.2 12916
4 EX-32.1 eyen-20230331xex32d1.htm EX-32.1 6542
5 EX-32.2 eyen-20230331xex32d2.htm EX-32.2 6185
  Complete submission text file 0001410578-23-001063.txt   5189727

Data Files

Seq Description Document Type Size
6 EX-101.SCH eyen-20230331.xsd EX-101.SCH 46490
7 EX-101.CAL eyen-20230331_cal.xml EX-101.CAL 44406
8 EX-101.DEF eyen-20230331_def.xml EX-101.DEF 119849
9 EX-101.LAB eyen-20230331_lab.xml EX-101.LAB 322234
10 EX-101.PRE eyen-20230331_pre.xml EX-101.PRE 259095
52 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20230331x10q_htm.xml XML 941332
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 23913500
SIC: 2834 Pharmaceutical Preparations